Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

PIH
1347 Property Insurance Holdings Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 29 Sep 2020 29 Jun 2020 30 Mar 2020 30 Dec 2019
Current assets
Cash $15.233 $25.638 $27.668 $28.509
Short term investments
Net receivables $2.793 $1.849 $1.824 $1.311
Inventory
Total current assets $18.569 $28.18 $29.797 $29.962
Long term investments $18.387 $23.637 $24.455 $33.492
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $36.956 $51.821 $54.783 $63.454
Current liabilities
Accounts payable $0.48 $0.294 $0.406 $0.4
Deferred revenue
Short long term debt
Total current liabilities $0.48 $0.294 $0.406 $0.4
Long term debt
Total noncurrent liabilities
Total debt
Total liabilities $0.562 $0.37 $0.463 $0.539
Stockholders' equity
Retained earnings -$21.844 -$11.904 -$8.983 -$0.336
Other stockholder equity
Total stockholder equity $18.894 $33.951 $36.82 $45.415
(in millions USD) 2019 2018 2017
Current assets
Cash $28.509 $3.666 $23.575
Short term investments $0.474 $0.417
Net receivables $1.311 $0.002 $10.904
Inventory
Total current assets $29.962 $148.302 $46.698
Long term investments $33.492 $2.987 $54.774
Property, plant & equipment $0.315 $0.205
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $63.454 $169.798 $114.437
Current liabilities
Accounts payable $0.4 $0.066 $6.23
Deferred revenue
Short long term debt
Total current liabilities $0.4 $104.317 $51.307
Long term debt $2.84
Total noncurrent liabilities
Total debt
Total liabilities $0.539 $107.051 $67.635
Stockholders' equity
Retained earnings -$0.336 $0.639 $0.91
Other stockholder equity -$0.729 -$0.169
Total stockholder equity $45.415 $45.247 $46.802

Income statement

XSLX
XSLX
(in millions USD) 29 Sep 2020 29 Jun 2020 30 Mar 2020 30 Dec 2019
Revenue
Total revenue -$7.69 -$0.546 -$8.677 $4.34
Cost of revenue
Gross profit -$7.69 -$0.546 -$8.677 $4.34
Operating activities
Research & development
Selling, general & administrative $1.9 $1.505 $0.805 -$0.76
Total operating expenses $1.9 $1.505 $0.805 -$0.76
Operating income -$9.59 -$2.051 -$9.482 $5.1
Income from continuing operations
EBIT -$9.59 -$2.051 -$9.482 $5.1
Income tax expense $0.52 -$1.185 $0.9
Interest expense
Net income
Net income -$9.59 -$2.571 -$8.297 $8.28
Income (for common shares) -$9.94 -$2.921 -$8.647 $7.93
(in millions USD) 2019 2018 2017
Revenue
Total revenue $5.597 $1.208 $38.148
Cost of revenue $42.726 $26.98
Gross profit $5.597 $1.208 $11.168
Operating activities
Research & development
Selling, general & administrative $2.476 $1.145 $9.304
Total operating expenses $2.476 $1.145 $36.284
Operating income $3.121 $0.063 $1.864
Income from continuing operations
EBIT $3.121 $0.063 $1.864
Income tax expense $0.738 -$0.308 $1.198
Interest expense -$0.033 -$0.372
Net income
Net income $0.311 $0.804 $0.294
Income (for common shares) -$1.089 -$0.304 $0.294

Cash flows

XSLX
XSLX
(in millions USD) 29 Sep 2020 29 Jun 2020 30 Mar 2020 30 Dec 2019
Net income -$9.59 -$2.571 -$8.297 $8.28
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$2.22 -$1.771 -$0.491 -$14.407
Investing activities
Capital expenditures -$0.003 -$0.003 -$0.003 -$0.003
Investments -$5.294 $0.091 $0.091 $0.091
Total cash flows from investing -$5.297 $0.091 $0.091 $6.707
Financing activities
Dividends paid -$0.35 -$0.35 -$0.35 -$0.35
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$2.888 -$0.35 -$0.35 -$0.357
Effect of exchange rate
Change in cash and equivalents -$10.405 -$2.03 -$0.841 -$8.057
(in millions USD) 2019 2018 2017
Net income $0.311 $0.804 $0.294
Operating activities
Depreciation $0.124 $0.073
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$20.638 $24.794 $7.527
Investing activities
Capital expenditures -$0.003 -$0.052 -$0.028
Investments -$1.007 -$2.987 -$26.953
Total cash flows from investing $19.684 -$29.247 -$26.981
Financing activities
Dividends paid -$1.4 -$1.348 -$0.24
Sale and purchase of stock
Net borrowings -$0.065 -$0.065
Total cash flows from financing -$1.439 $11.78 -$0.016
Effect of exchange rate
Change in cash and equivalents -$2.393 $7.327 -$19.47

FLWS
1-800 Flowers.com Inc.
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $159.437 $183.956 $312.017 $8.375
Short term investments
Net receivables $18.024 $26.779 $46.578 $44.239
Inventory $176.591 $159.458 $161.324 $280.621
Total current assets $385.732 $396.63 $544.476 $382.582
Long term investments
Property, plant & equipment $337.715 $338.723 $345.468 $349.692
Goodwill & intangible assets $272.753 $270.36 $271.474 $292.149
Total noncurrent assets $646.916 $643.352 $647.234 $668.766
Total investments
Total assets $1,032.648 $1,039.982 $1,191.71 $1,051.348
Current liabilities
Accounts payable $80.005 $47.015 $92.418 $51.764
Deferred revenue
Short long term debt $26.511 $25.25 $25.433 $60.58
Total current liabilities $227.819 $210.269 $341.935 $255.039
Long term debt $282.979 $287.35 $292.489 $297.349
Total noncurrent liabilities $338.487 $344.387 $346.415 $353.418
Total debt $309.49 $312.6 $317.922 $357.929
Total liabilities $566.306 $554.656 $688.35 $608.457
Stockholders' equity
Retained earnings $264.978 $285.845 $302.748 $239.841
Other stockholder equity -$0.127 -$0.17 -$0.17 -$0.17
Total stockholder equity $466.342 $485.326 $503.36 $442.891
(in millions USD) 2024 2023 2022
Current assets
Cash $159.437 $126.807 $31.465
Short term investments
Net receivables $18.024 $20.419 $23.812
Inventory $176.591 $191.334 $247.563
Total current assets $385.732 $373.143 $348.238
Long term investments
Property, plant & equipment $337.715 $359.284 $365.871
Goodwill & intangible assets $272.753 $293.264 $358.855
Total noncurrent assets $646.916 $678.287 $746.653
Total investments
Total assets $1,032.648 $1,051.43 $1,094.891
Current liabilities
Accounts payable $80.005 $52.588 $57.386
Deferred revenue
Short long term debt $26.511 $25.759 $32.919
Total current liabilities $227.819 $220.261 $265.697
Long term debt $282.979 $303.721 $266.159
Total noncurrent liabilities $338.487 $359.326 $319.785
Total debt $309.49 $329.48 $299.078
Total liabilities $566.306 $579.587 $585.482
Stockholders' equity
Retained earnings $264.978 $271.083 $315.785
Other stockholder equity -$0.127 -$0.17 -$0.211
Total stockholder equity $466.342 $471.843 $509.409

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $360.912 $379.405 $822.054 $269.05
Cost of revenue $222.501 $240.688 $466.357 $167.122
Gross profit $138.411 $138.717 $355.697 $101.928
Operating activities
Research & development $14.818 $15.291 $14.822 $15.304
Selling, general & administrative $138.235 $138.123 $215.711 $111.007
Total operating expenses $166.227 $166.646 $264.447 $139.505
Operating income -$27.816 -$27.929 $91.25 -$37.577
Income from continuing operations
EBIT -$26.859 -$24.355 $93.986 -$38.051
Income tax expense -$7.641 -$8.333 $26.468 -$10.291
Interest expense $1.649 $0.881 $4.611 $3.482
Net income
Net income -$20.867 -$16.903 $62.907 -$31.242
Income (for common shares) -$20.867 -$16.903 $62.907 -$31.242
(in millions USD) 2024 2023 2022
Revenue
Total revenue $1,831.421 $2,017.853 $2,207.885
Cost of revenue $1,096.668 $1,260.327 $1,386.147
Gross profit $734.753 $757.526 $821.738
Operating activities
Research & development $60.235 $60.691 $56.561
Selling, general & administrative $603.076 $613.587 $673.998
Total operating expenses $736.825 $792.537 $779.637
Operating income -$2.072 -$35.011 $42.101
Income from continuing operations
EBIT $4.721 -$35.816 $36.769
Income tax expense $0.203 -$2.06 $1.492
Interest expense $10.623 $10.946 $5.667
Net income
Net income -$6.105 -$44.702 $29.61
Income (for common shares) -$6.105 -$44.702 $29.61

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income -$20.867 -$16.903 $62.907 -$31.242
Operating activities
Depreciation $13.174 $13.232 $14.152 $13.194
Business acquisitions & disposals -$3.672
Stock-based compensation $3.047 $3.046 $2.231 $2.364
Total cash flows from operations -$5.052 -$112.709 $356.644 -$143.884
Investing activities
Capital expenditures -$12.15 -$8.675 -$10.833 -$6.974
Investments
Total cash flows from investing -$15.822 -$8.675 -$10.833 -$6.974
Financing activities
Dividends paid
Sale and purchase of stock -$1.145 -$4.177 -$4.669 -$0.074
Net borrowings -$2.5 -$2.5 -$37.5 $32.5
Total cash flows from financing -$3.645 -$6.677 -$42.169 $32.426
Effect of exchange rate
Change in cash and equivalents -$24.519 -$128.061 $303.642 -$118.432
(in millions USD) 2024 2023 2022
Net income -$6.105 -$44.702 $29.61
Operating activities
Depreciation $53.752 $53.673 $49.078
Business acquisitions & disposals -$3.672 -$6.151 -$21.28
Stock-based compensation $10.688 $8.334 $7.947
Total cash flows from operations $94.999 $115.351 $5.189
Investing activities
Capital expenditures -$38.632 -$44.646 -$66.408
Investments -$0.032 -$2
Total cash flows from investing -$42.304 -$50.829 -$89.688
Financing activities
Dividends paid
Sale and purchase of stock -$10.065 -$1.239 -$37.325
Net borrowings -$10 $32.059 -$20.284
Total cash flows from financing -$20.065 $30.82 -$57.609
Effect of exchange rate
Change in cash and equivalents $32.63 $95.342 -$142.108

SRCE
1st Source Corp.
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $269.243 $80.914 $129.668 $111.135
Short term investments
Net receivables
Inventory
Total current assets
Long term investments
Property, plant & equipment $62.087 $62.38 $66.525 $68.047
Goodwill & intangible assets $83.907 $83.912 $83.916 $83.921
Total noncurrent assets
Total investments $8,053.828 $8,025.948 $8,020.07 $7,843.009
Total assets $8,878.003 $8,667.837 $8,727.958 $8,525.058
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $386.117 $347.75 $419.034 $377.389
Total liabilities $7,763.148 $7,586.288 $7,659.695 $7,542.061
Stockholders' equity
Retained earnings $841.79 $812.413 $789.842 $769.603
Other stockholder equity -$105.565 -$109.275 -$106.323 -$151.312
Total stockholder equity $1,043.515 $1,009.886 $989.568 $924.25
(in millions USD) 2023 2022 2021
Current assets
Cash $129.668 $122.797 $525.187
Short term investments
Net receivables
Inventory
Total current assets
Long term investments
Property, plant & equipment $66.525 $76.473 $95.471
Goodwill & intangible assets $83.916 $83.907 $83.926
Total noncurrent assets
Total investments $8,020.07 $7,676.229 $7,122.236
Total assets $8,727.958 $8,339.416 $8,096.289
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities
Long term debt
Total noncurrent liabilities
Total debt $419.034 $320.848 $330.042
Total liabilities $7,659.695 $7,415.65 $7,126.825
Stockholders' equity
Retained earnings $789.842 $694.862 $603.787
Other stockholder equity -$106.323 -$147.69 -$9.861
Total stockholder equity $989.568 $864.068 $916.255

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $97.215 $87.476 $89.495 $92.832
Cost of revenue
Gross profit $97.215 $87.476 $89.495 $92.832
Operating activities
Research & development
Selling, general & administrative $42.149 $41.961 $43.229 $40.44
Total operating expenses $49.491 $49.586 $52.972 $50.166
Operating income $47.724 $37.89 $36.523 $42.666
Income from continuing operations
EBIT $47.712 $37.883 $36.535 $42.666
Income tax expense $10.919 $8.428 $8.106 $9.727
Interest expense
Net income
Net income $36.793 $29.455 $28.429 $32.939
Income (for common shares) $36.793 $29.455 $28.429 $32.939
(in millions USD) 2023 2022 2021
Revenue
Total revenue $363.404 $341.486 $341.033
Cost of revenue
Gross profit $363.404 $341.486 $341.033
Operating activities
Research & development
Selling, general & administrative $164.567 $149.484 $156.141
Total operating expenses $201.724 $184.699 $186.148
Operating income $161.68 $156.787 $154.885
Income from continuing operations
EBIT $161.673 $156.764 $154.862
Income tax expense $36.746 $36.255 $36.328
Interest expense
Net income
Net income $124.927 $120.509 $118.534
Income (for common shares) $124.927 $120.509 $118.534

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $36.793 $29.455 $28.429 $32.939
Operating activities
Depreciation $3.017 $3.263 $3.501 $3.768
Business acquisitions & disposals
Stock-based compensation $1.215 $1.31 $1.483 $1.168
Total cash flows from operations $49.986 $41.96 $44.15 $52.159
Investing activities
Capital expenditures -$1.774 $1.825 -$1.032 -$0.163
Investments -$30.826 -$26.42 -$147.689 -$110.53
Total cash flows from investing -$31.851 -$23.69 -$148.278 -$109.968
Financing activities
Dividends paid -$8.598 -$8.592 -$8.59 -$8.171
Sale and purchase of stock $0.153 $0.002 -$10.293
Net borrowings $38.361 -$74.043 $40.2 $84.079
Total cash flows from financing $170.194 -$67.024 $122.661 $56.269
Effect of exchange rate
Change in cash and equivalents $188.329 -$48.754 $18.533 -$1.54
(in millions USD) 2023 2022 2021
Net income $124.927 $120.509 $118.534
Operating activities
Depreciation $15.463 $19.087 $23.999
Business acquisitions & disposals
Stock-based compensation $4.891 $3.587 $4.214
Total cash flows from operations $187.936 $175.53 $166.761
Investing activities
Capital expenditures -$1.597 $4.379 $0.156
Investments -$358.793 -$783.795 -$603.234
Total cash flows from investing -$358.286 -$784.872 -$598.559
Financing activities
Dividends paid -$33.074 -$32.102 -$31.34
Sale and purchase of stock -$12.391 -$6.584 -$33.046
Net borrowings $93.38 -$10.028 $35.926
Total cash flows from financing $177.221 $206.952 $713.938
Effect of exchange rate
Change in cash and equivalents $6.871 -$402.39 $282.14

ACIA
Acacia Communications Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Current assets
Cash $121.685 $211.224 $245.534 $86.01
Short term investments $298.185 $244.458 $198.125 $281.686
Net receivables $118.414 $137.246 $115.109 $96.826
Inventory $37.981 $35.195 $32.457 $36.3
Total current assets $584.288 $636.764 $599.176 $509.002
Long term investments $170.891 $83.477 $70.718 $122.545
Property, plant & equipment $56.397 $57.657 $57.086 $56.524
Goodwill & intangible assets
Total noncurrent assets $277.476 $194.242 $181.09 $232.043
Total investments $469.076 $327.935 $268.843 $404.231
Total assets $861.764 $831.006 $780.266 $741.045
Current liabilities
Accounts payable $61.489 $65.355 $53.653 $43.578
Deferred revenue $5.754 $6.973 $4.033 $3.496
Short long term debt
Total current liabilities $129.471 $139.659 $119.957 $105.598
Long term debt $18.099 $18.972 $19.182 $19.71
Total noncurrent liabilities $28.477 $30.244 $31 $32.807
Total debt $18.099 $18.972 $19.182 $19.71
Total liabilities $157.948 $169.903 $150.957 $138.405
Stockholders' equity
Retained earnings $305.77 $271.393 $247.104 $231.023
Other stockholder equity $0.469 $0.886 $1.498 -$0.293
Total stockholder equity $703.816 $661.103 $629.309 $602.64
(in millions USD) 2020 2019 2018
Current assets
Cash $121.685 $36.617 $60.444
Short term investments $298.185 $300.129 $264.66
Net receivables $118.414 $97.948 $90.831
Inventory $37.981 $40.82 $25.511
Total current assets $584.288 $482.032 $454.044
Long term investments $170.891 $134.632 $74.764
Property, plant & equipment $56.397 $51.847 $26.643
Goodwill & intangible assets
Total noncurrent assets $277.476 $239.383 $147.815
Total investments $469.076 $434.761 $339.424
Total assets $861.764 $721.415 $601.859
Current liabilities
Accounts payable $61.489 $46.957 $46.65
Deferred revenue $5.754 $4.483 $5.101
Short long term debt
Total current liabilities $129.471 $113.12 $83.599
Long term debt $18.099 $15.726
Total noncurrent liabilities $28.477 $29.872 $15.533
Total debt $18.099 $15.726
Total liabilities $157.948 $142.992 $99.132
Stockholders' equity
Retained earnings $305.77 $215.379 $182.54
Other stockholder equity $0.469 $0.72 -$0.372
Total stockholder equity $703.816 $578.423 $502.727

Income statement

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Revenue
Total revenue $164.154 $158.456 $135.215 $125.626
Cost of revenue $84.459 $78.541 $70.007 $66.344
Gross profit $79.695 $79.915 $65.208 $59.282
Operating activities
Research & development $29.844 $39.884 $32.575 $32.095
Selling, general & administrative $12.657 $15.082 $18.276 $14.371
Total operating expenses $42.501 $54.966 $50.851 $46.466
Operating income $37.194 $24.949 $14.357 $12.816
Income from continuing operations
EBIT $37.885 $25.944 $15.948 $15.066
Income tax expense $3.508 $1.655 -$0.133 -$0.578
Interest expense
Net income
Net income $34.377 $24.289 $16.081 $15.644
Income (for common shares) $34.377 $24.289 $16.081 $15.644
(in millions USD) 2020 2019 2018
Revenue
Total revenue $583.451 $464.663 $339.891
Cost of revenue $299.351 $243.981 $192.771
Gross profit $284.1 $220.682 $147.12
Operating activities
Research & development $134.398 $128.7 $102.406
Selling, general & administrative $60.386 $80.581 $51.864
Total operating expenses $194.784 $209.281 $154.27
Operating income $89.316 $11.401 -$7.15
Income from continuing operations
EBIT $94.843 $21.641 -$0.404
Income tax expense $4.452 -$11.198 -$5.32
Interest expense
Net income
Net income $90.391 $32.839 $4.916
Income (for common shares) $90.391 $32.839 $4.916

Cash flows

XSLX
XSLX
(in millions USD) 31 Dec 2020 30 Sep 2020 30 Jun 2020 31 Mar 2020
Net income $34.377 $24.289 $16.081 $15.644
Operating activities
Depreciation $4.269 $4.061 $3.433 $3.876
Business acquisitions & disposals
Stock-based compensation $7.447 $8.048 $8.784 $9.384
Total cash flows from operations $53.917 $29.728 $25.352 $22.055
Investing activities
Capital expenditures -$2.413 -$4.277 -$3.447 -$2.742
Investments -$142.517 -$59.99 $137.469 $29.757
Total cash flows from investing -$144.93 -$64.267 $134.022 $27.015
Financing activities
Dividends paid
Sale and purchase of stock $1.474 $0.229 $0.15 $0.323
Net borrowings
Total cash flows from financing $1.474 $0.229 $0.15 $0.323
Effect of exchange rate
Change in cash and equivalents -$89.539 -$34.31 $159.524 $49.393
(in millions USD) 2020 2019 2018
Net income $90.391 $32.839 $4.916
Operating activities
Depreciation $15.639 $17.431 $13.646
Business acquisitions & disposals
Stock-based compensation $33.663 $35.153 $29.593
Total cash flows from operations $131.052 $72.819 $83.085
Investing activities
Capital expenditures -$12.879 -$11.837 -$14.66
Investments -$35.281 -$91.742 -$41.577
Total cash flows from investing -$48.16 -$103.579 -$56.237
Financing activities
Dividends paid
Sale and purchase of stock $2.176 $6.933 -$33.899
Net borrowings
Total cash flows from financing $2.176 $6.933 -$33.899
Effect of exchange rate
Change in cash and equivalents $85.068 -$23.827 -$7.051

ADMA
Adma Biologics Inc
Compare

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $88.244 $45.325 $51.352 $74.156765
Short term investments
Net receivables $30.113 $49.621 $27.421 $31.31868
Inventory $179.81 $177.732 $172.906 $163.116105
Total current assets $303.691 $276.419 $257.013 $273.699005
Long term investments
Property, plant & equipment $63.478 $64.714 $63.47 $64.568332
Goodwill & intangible assets $4.009 $3.851 $4.029 $4.006411
Total noncurrent assets $72.708 $74.456 $72.169 $75.29756
Total investments
Total assets $376.399 $350.875 $329.182 $348.996565
Current liabilities
Accounts payable $14.179 $17.186 $15.66 $10.851446
Deferred revenue $2.749 $2.772 $1.872 $1.86874
Short long term debt $1.142 $1.093 $1.045 $0.982891
Total current liabilities $44.177 $53.088 $49.806 $41.840897
Long term debt $131.074 $130.847 $130.594 $142.025542
Total noncurrent liabilities $143.953 $144.081 $144.17 $155.718322
Total debt $132.216 $131.94 $131.639 $143.008433
Total liabilities $188.13 $197.169 $193.976 $197.559219
Stockholders' equity
Retained earnings -$456.388 -$488.45 -$506.256 -$488.611138
Other stockholder equity
Total stockholder equity $188.269 $153.706 $135.206 $151.437346
(in millions USD) 2023 2022 2021
Current assets
Cash $51.352 $86.521542 $51.089118
Short term investments
Net receivables $27.421 $15.505048 $28.576857
Inventory $172.906 $163.280047 $124.724091
Total current assets $257.013 $270.401783 $208.729311
Long term investments
Property, plant & equipment $63.47 $68.746928 $58.197732
Goodwill & intangible assets $4.029 $4.542924 $5.258277
Total noncurrent assets $72.169 $78.060098 $67.523413
Total investments
Total assets $329.182 $348.461881 $276.252724
Current liabilities
Accounts payable $15.66 $13.22939 $12.429409
Deferred revenue $1.872 $1.975865 $2.118699
Short long term debt $1.045 $0.905369 $0.591084
Total current liabilities $49.806 $39.266942 $30.378315
Long term debt $130.594 $142.833063 $94.866239
Total noncurrent liabilities $144.17 $157.220724 $104.701843
Total debt $131.639 $143.738432 $95.457323
Total liabilities $193.976 $196.487666 $135.080158
Stockholders' equity
Retained earnings -$506.256 -$478.016671 -$412.112721
Other stockholder equity
Total stockholder equity $135.206 $151.974215 $141.172566

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $107.191 $81.875 $73.903677 $67.274598
Cost of revenue $49.738 $42.767 $42.817255 $42.622013
Gross profit $57.453 $39.108 $31.086422 $24.652585
Operating activities
Research & development $0.56 $0.45 $0.445486 $0.595903
Selling, general & administrative $16.608 $15.639 $15.534999 $14.725787
Total operating expenses $18.252 $17.287 $16.853186 $15.967426
Operating income $39.201 $21.821 $14.233236 $8.685159
Income from continuing operations
EBIT $39.634 $22.17 -$11.429677 $8.962608
Income tax expense $3.789 $0.595
Interest expense $3.783 $3.769 $6.214856 $6.397553
Net income
Net income $32.062 $17.806 -$17.644533 $2.565055
Income (for common shares) $32.062 $17.806 -$17.644533 $2.565055
(in millions USD) 2023 2022 2021
Revenue
Total revenue $258.215 $154.079692 $80.942625
Cost of revenue $169.273 $118.814535 $79.769341
Gross profit $88.942 $35.265157 $1.173284
Operating activities
Research & development $3.3 $3.613764 $3.64606
Selling, general & administrative $59.02 $52.458024 $42.896889
Total operating expenses $67.31 $74.630237 $59.547025
Operating income $21.632 -$39.36508 -$58.373741
Income from continuing operations
EBIT -$3.212 -$46.624577 -$58.590784
Income tax expense
Interest expense $25.027 $19.279373 $13.056834
Net income
Net income -$28.239 -$65.90395 -$71.647618
Income (for common shares) -$28.239 -$65.90395 -$71.647618

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $32.062 $17.806 -$17.644533 $2.565055
Operating activities
Depreciation $2.047 $2.114 $2.10895 $2.092508
Business acquisitions & disposals
Stock-based compensation $2.863 $2.141 $1.745155 $1.694641
Total cash flows from operations $45.646 -$2.218 $17.595952 $11.985078
Investing activities
Capital expenditures -$2.066 -$2.347 -$1.197214 -$0.756557
Investments
Total cash flows from investing -$2.365 -$2.362 -$1.407214 -$0.756557
Financing activities
Dividends paid
Sale and purchase of stock $0.331 $1.029 $0.008461 $0.623993
Net borrowings -$25.170972
Total cash flows from financing -$0.362 -$1.447 -$38.993961 $0.415355
Effect of exchange rate
Change in cash and equivalents $42.919 -$6.027 -$22.805223 $11.643876
(in millions USD) 2023 2022 2021
Net income -$28.239 -$65.90395 -$71.647618
Operating activities
Depreciation $8.332 $7.113369 $5.495502
Business acquisitions & disposals
Stock-based compensation $6.187 $5.214531 $3.488253
Total cash flows from operations $8.8 -$59.508257 -$112.368982
Investing activities
Capital expenditures -$4.771 -$13.911171 -$13.511258
Investments
Total cash flows from investing -$4.981 -$13.911171 -$13.511258
Financing activities
Dividends paid
Sale and purchase of stock $1.104 $64.820304 $121.144103
Net borrowings -$25.187 $51.713316 -$0.034299
Total cash flows from financing -$38.989 $108.851852 $121.048206
Effect of exchange rate
Change in cash and equivalents -$35.17 $35.432424 -$4.832034